Suppr超能文献

CE:实施阿片类药物治疗慢性疼痛指南。

CE: Implementing Guidelines for Treating Chronic Pain with Prescription Opioids.

机构信息

Patricia E. Maloy is a nurse care manager at the VA Portland Health Care System, Portland, OR, where Benjamin J. Morasco is principal investigator and, at the time of this writing, Megan O. Iacocca was a clinical research associate. Iacocca is currently a research associate at Kaiser Permanente in Portland. Contact author: Patricia E. Maloy,

出版信息

Am J Nurs. 2019 Nov;119(11):22-29. doi: 10.1097/01.NAJ.0000605344.99391.78.

Abstract

Chronic pain, stemming primarily from musculoskeletal conditions and severe headaches, is a growing problem in the United States, affecting as many as 43% of adults. Opioids are frequently prescribed to manage chronic pain despite limited data on their long-term efficacy and the potential risks of long-term use. In 2017, more than 47,000 people died as a result of an opioid overdose involving illicit opioids (such as heroin), illicitly manufactured opioids, diverted opioids, prescription opioids, or some combination thereof. Although it's been more than three years since the nationwide opioid crisis prompted the Centers for Disease Control and Prevention (CDC) to release a guideline outlining safe practices for prescribing opioids to patients with chronic pain (unrelated to active cancer or palliative and end-of-life care), opioid misuse remains a significant concern. Historically, physicians have been tasked with the primary responsibility for implementing opioid safety measures, but nurses in the primary care setting are being increasingly relied on to incorporate these measures as part of their practice. In this article, we discuss the use of five tools outlined in the CDC guideline: prescription opioid treatment agreements, urine drug screening, prescription drug monitoring program databases, calculation of morphine milligram equivalents, and naloxone kits. Primary care nurses can use these tools to promote opioid safety among patients receiving opioid therapy for chronic pain.

摘要

慢性疼痛主要源自肌肉骨骼疾病和严重头痛,是美国日益严重的问题,多达 43%的成年人受其影响。尽管关于阿片类药物长期疗效和长期使用潜在风险的数据有限,但仍经常开阿片类药物来治疗慢性疼痛。2017 年,超过 47000 人因涉及非法阿片类药物(如海洛因)、非法制造的阿片类药物、转移的阿片类药物、处方阿片类药物或某种组合的阿片类药物过量而死亡。尽管自全国性阿片类药物危机促使疾病控制与预防中心(CDC)发布指导方针概述为慢性疼痛(与活动性癌症或姑息治疗和临终关怀无关)患者开具阿片类药物的安全实践以来已经过去了三年多,但阿片类药物滥用仍然是一个严重的问题。从历史上看,医生承担着实施阿片类药物安全措施的主要责任,但初级保健环境中的护士越来越多地被要求将这些措施纳入其实践。在本文中,我们讨论了 CDC 指南中概述的五种工具的使用:阿片类药物治疗协议、尿液药物筛查、处方药物监测计划数据库、吗啡毫克当量计算和纳洛酮试剂盒。初级保健护士可以使用这些工具来促进接受慢性疼痛阿片类药物治疗的患者的阿片类药物安全。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验